Peptide profile
Nerinetide
Also known as NA-1
Peptide inhibitor of postsynaptic density protein 95 signaling
Clinical research
Science, with its context intact.What to knowThe evidence
The evidence
in perspective.
The ESCAPE-NA1 trial did not improve the primary functional outcome overall after thrombectomy. Preclinical neuroprotection did not establish clinical efficacy in that trial.
View the supporting source- Research area
- Neuroscience
- Biological target or mechanism
- Peptide inhibitor of postsynaptic density protein 95 signaling
- Evidence context
- Clinical research
- Availability
- Availability requires pharmacy review
From information to a conversationClinical decisions stay
Clinical decisions stay
with clinical professionals.
This profile is a research reference. Your prescriber and pharmacy assess the relevant clinical and dispensing pathway. Inclusion here is not an offer to sell this compound.
